{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:45:32Z","timestamp":1785894332760,"version":"3.56.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["2025J181"],"award-info":[{"award-number":["2025J181"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303144"],"award-info":[{"award-number":["82303144"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32470722"],"award-info":[{"award-number":["32470722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004387","name":"Ningbo University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014759","name":"Medical Scientific Research Foundation of Zhejiang Province, China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014759","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.intimp.2026.117057","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T18:44:40Z","timestamp":1781981080000},"page":"117057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Gemcitabine enhanced the sensitivity of colorectal cancer to anti-PD-L1 therapy by promoting lactylation"],"prefix":"10.1016","volume":"185","author":[{"given":"Jing","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjiang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.intimp.2026.117057_bb0005","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3748\/wjg.v30.i7.644","article-title":"Colon and rectal cancer: an emergent public health problem","volume":"30","author":"Pinheiro","year":"2024","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117057_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101174","article-title":"Global colorectal cancer burden in 2020 and projections to 2040","volume":"14","author":"Xi","year":"2021","journal-title":"Transl. Oncol."},{"issue":"8","key":"10.1016\/j.intimp.2026.117057_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16081530","article-title":"Colorectal cancer: epidemiology, risk factors, and prevention","volume":"16","author":"Roshandel","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.intimp.2026.117057_bb0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.intimp.2026.117057_bb0025","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2026.117057_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01624","article-title":"Colorectal Cancer immunotherapy: options and strategies","volume":"11","author":"Johdi","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2026.117057_bb0035","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.trecan.2024.05.001","article-title":"Advancements in combining targeted therapy and immunotherapy for colorectal cancer","volume":"10","author":"Singh","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.intimp.2026.117057_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1105180","article-title":"Radioimmunotherapy in colorectal cancer treatment: present and future","volume":"14","author":"Shi","year":"2023","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117057_bb0045","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41571-020-0413-z","article-title":"Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors","volume":"17","author":"Galluzzi","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117057_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021702","article-title":"Current targeted therapy for metastatic colorectal Cancer","volume":"24","author":"Ohishi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117057_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177294","article-title":"Beyond chemotherapy: exploring 5-FU resistance and stemness in colorectal cancer","volume":"991","author":"Singh","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117057_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2026.117057_bb0065","article-title":"Colorectal cancer-derived small extracellular vesicles promote tumor immune evasion by upregulating PD-L1 expression in tumor-associated macrophages","volume":"9","author":"Yin","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.intimp.2026.117057_bb0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2019.12.018","article-title":"Tumor immunology and tumor evolution: intertwined histories","volume":"52","author":"Galon","year":"2020","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.intimp.2026.117057_bb0075","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1001\/jamaoncol.2023.3323","article-title":"Neoadjuvant immune checkpoint inhibitor therapy for localized deficient mismatch repair colorectal cancer: a review","volume":"9","author":"Emiloju","year":"2023","journal-title":"JAMA Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117057_bb0080","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1007\/s00262-023-03520-5","article-title":"PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies","volume":"72","author":"Lin","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"19","key":"10.1016\/j.intimp.2026.117057_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194755","article-title":"Tumor-associated neutrophils in colorectal Cancer development, progression and immunotherapy","volume":"14","author":"Zheng","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"Suppl. 5","key":"10.1016\/j.intimp.2026.117057_bb0090","doi-asserted-by":"crossref","first-page":"v7","DOI":"10.1093\/annonc\/mdj941","article-title":"Cellular pharmacology of gemcitabine","volume":"17","author":"Mini","year":"2006","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117057_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/genes13030466","article-title":"Recent development of prodrugs of gemcitabine","volume":"13","author":"Pandit","year":"2022","journal-title":"Genes"},{"issue":"10","key":"10.1016\/j.intimp.2026.117057_bb0100","article-title":"Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response","volume":"4","author":"Tang","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"6","key":"10.1016\/j.intimp.2026.117057_bb0105","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/s41591-023-02369-6","article-title":"The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment","volume":"29","author":"Lv","year":"2023","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.intimp.2026.117057_bb0110","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1634\/theoncologist.2017-0206","article-title":"Prolonged pemetrexed infusion plus gemcitabine in refractory metastatic colorectal Cancer: preclinical rationale and phase II study results","volume":"22","author":"Passardi","year":"2017","journal-title":"Oncologist"},{"issue":"Suppl. 3","key":"10.1016\/j.intimp.2026.117057_bb0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/bjc.1998.750","article-title":"The role of gemcitabine in the treatment of other tumours","volume":"78","author":"Carmichael","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2026.117057_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1170526","article-title":"Comprehensive analysis identifies novel targets of gemcitabine to improve chemotherapy treatment strategies for colorectal cancer","volume":"14","author":"Zeng","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"7","key":"10.1016\/j.intimp.2026.117057_bb0125","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","article-title":"The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression","volume":"95","author":"Vaupel","year":"2019","journal-title":"Int. J. Radiat. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117057_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01358-5","article-title":"Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications","volume":"15","author":"Zhong","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117057_bb0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cpt.2024.09.006","article-title":"Claudin-9 (CLDN9) promotes gastric cancer progression by enhancing the glycolysis pathway and facilitating PD-L1 lactylation to suppress CD8(+) T cell anti-tumor immunity","volume":"3","author":"Hu","year":"2025","journal-title":"Cancer Pathog. Ther."},{"issue":"33","key":"10.1016\/j.intimp.2026.117057_bb0140","article-title":"NDRG1-driven lactate accumulation promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment","volume":"12","author":"Wu","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"issue":"9","key":"10.1016\/j.intimp.2026.117057_bb0145","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1517\/13543780903136724","article-title":"Is there a palliative benefit of gemcitabine plus fluoropyrimidines in patients with refractory colorectal cancer? A review of the literature previously presented: poster at the 2008 Gastrointestinal Cancer Symposium (Abstract No. 512)","volume":"18","author":"Merl","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"12","key":"10.1016\/j.intimp.2026.117057_bb0150","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.cmet.2024.10.019","article-title":"Dual impacts of serine\/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation","volume":"36","author":"Tong","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2026.117057_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1554372","article-title":"Post-translational modifications in hepatocellular carcinoma: unlocking new frontiers in immunotherapy","volume":"16","author":"Piao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117057_bb0160","article-title":"Lactate-related metabolic reprogramming and immune regulation in colorectal cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.intimp.2026.117057_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-026-08589-1","article-title":"Lactylation stabilizes PD-L1 to promote tumor immune evasion and cell growth","volume":"17","author":"Liang","year":"2026","journal-title":"Cell Death Dis."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:49:59Z","timestamp":1785890999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926009033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"alternative-id":["S1567576926009033"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117057","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gemcitabine enhanced the sensitivity of colorectal cancer to anti-PD-L1 therapy by promoting lactylation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117057"}}